In acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) triggers cell differentiation, while arsenic trioxide (As 2 O 3 ) generates partial differentiation and apoptosis. Animal and human studies suggest that newly diagnosed APL patients can be cured using As 2 O 3 combined with ATRA. Cyclooxygenases are involved in prostaglandins and thromboxane synthesis. We have recently demonstrated that ATRA induces cyclooxygenase-1 (COX-1) expression and prostaglandin synthesis in NB4 cells and in blasts from patients with APL. In the present study we investigated the effect of ATRA and As 2 O 3 co-treatment on COX-1 expression and prostaglandin formation and tested the effect of the COX-1/COX-2 nonselective inhibitor indomethacin on cell differentiation. Arsenic treatment of NB4 cells resulted in a partial but significant reduction of ATRA-dependent induction of COX-1 expression and activity. Pretreatment of NB4 cells with indomethacin significantly impaired ATRA/As 2 O 3 -induced differentiation, as assessed by cell morphology, nitroblue tetrazolium test or CD11c expression. PGE 2 reversed the negative effect of indomethacin on differentiation of ATRA/As 2 O 3 -treated NB4 cells. In conclusion, COX-1 contributes to ATRA-dependent maturation of NB4 cells and is affected by As 2 O 3 . These results also suggest that nonsteroidal antiinflammatory drugs should be avoided in APL patients treated with the combination of ATRA and As 2 O 3 .
Introduction
Arsenic trioxide (As 2 O 3 ) is a very effective treatment for acute promyelocytic leukemia (APL) (reviewed in Sanz et al. 1 ), a distinct subtype of acute myeloid leukemia characterized by unique clinical and laboratory characteristics and a specific cytogenetic abnormality, t (15;17) , which results in a reciprocal translocation between the PML gene on chromosome 15 and the retinoic acid receptor-a (RAR-a) gene on chromosome 17.
2,3
The resulting chimeric protein arrests the maturation and proliferation of myeloid cells at the promyelocytic stage. The specific sensitivity of APL cells to all-trans retinoic acid (ATRA)-induced differentiation is well established, with however, a high incidence of relapse. Several large randomized and nonrandomized trials established the combination of ATRA plus anthracycline-based chemotherapy as the standard treatment for newly diagnosed APL, curing most of the patients. [4] [5] [6] Nevertheless, about 20% of patients who attain a complete remission will eventually relapse. Initial reports from China showed that APL patients resistant to ATRA and chemotherapy could still respond to As 2 O 3 . 7 Other studies confirmed these findings and showed that As 2 O 3 is more efficient than ATRA in reducing the degree of minimal residual APL cells. 1, 8, 9 The high complete remission rate with As 2 O 3 in relapsed APL led to its investigation in newly diagnosed patients. Animal and human studies using As 2 O 3 , either alone or combined with ATRA, suggest that patients with newly diagnosed APL can potentially be cured without or with minimal use of chemotherapy. [10] [11] [12] [13] At the cellular level, in vitro studies on APL-derived cell line (NB4) showed that As 2 O 3 triggers relatively specific NB4 cell apoptosis at micromolar concentration (reviewed in Zhu et al., 2002 14 ). Lower doses of arsenic were shown to induce differentiation of the leukemic cells (reviewed in Zhu et al., 2002 14 ) . At the molecular level, As 2 O 3 specifically leads to the degradation of the PML/RAR-a oncoprotein. 15 Prostanoids are derived from arachidonic acid via the cyclooxygenases and terminal prostaglandin (PG)/thromboxane synthases. 16 Cyclooxygenase-1 (COX-1) is the constitutive isoform of cyclooxygnease ubiquitously expressed in a majority of cells and tissues. COX-1 can be regulated during lymphoid maturation. [17] [18] [19] Retinoid isomers including ATRA and 9-cis-RA were described to induce COX-1 in human premonocytic U937 cells. 20 Retinoic acid was also described to induce COX-1 in human neuroblastoma cell lines 21 and COX-2 in synergy with platelet activating factor. 22 We have recently demonstrated that ATRA induces COX-1 but not COX-2 in NB4 cells and in blasts from patients with APL. 19 In the present study, we investigated the effect of co-treatment of NB4 cells with ATRA and As 2 O 3 on PG formation, COX-1 expression and cell differentiation. We found that As 2 O 3 inhibits ATRA-dependent COX-1 activity and expression in NB4 cells and that nonsteroidal antiinflammatory drugs (NSAIDs) significantly block differentiation of ATRA-and As 2 O 3 -treated NB4 cells. These results suggest that NSAIDs should be avoided in APL patients treated with the combination of ATRA and As 2 O 3 .
Materials and methods

Chemicals
All-trans retinoic acid (ATRA), As 2 24 These NB4 cells are derived from t(15;17) APL and are highly representative of the human APL pathophysiology. 24, 25 Freshly isolated APL blasts were obtained from one patient with APL after informed consent. Unless otherwise mentioned, cells were grown at 0.2 Â 10 6 per ml in the presence or absence of ATRA and As 2 O 3 . Cells were harvested on day 3, washed twice in phosphate-buffered saline and stained. In some experiments, 10 mM indomethacin, 10 mM SC58560 or 0.4 mM misoprostol were added. Vehicle concentrations did not exceed 0.1% and showed no significant effects on proliferation or differentiation.
Cyclooxygenase activity
The effect of ATRA and As 2 O 3 on cyclooxygenase activity and PGE 2 production was evaluated after addition of 10 mM of arachidonic acid. Following treatment, cells were washed once in Hanks buffer, pH 7.4 containing 1 mg ml À1 of BSA (bovine serum albumin) and further incubated for 30 min in the same buffer with 10 mM of arachidonic acid. Supernatants were collected and the concentration of PGE 2 was determined by enzyme immunoassay using acetylcholinesterase coupled to PGE 2 as tracer as previously described. 26 
Western blot analysis
At the end of treatment, cells were lysed in lysis buffer (Tris 20 mM/HCl, pH 8.0. containing 1% Triton X-100, 1 mM EDTA and 1 mM phenylmethysulfonylfluoride). Protein concentration was determined using the Bradford protein assay with BSA as standard. In total, 50 mg of total protein was analyzed on 10% SDS-polyacrylamide gel electrophoresis. Protein bands in the gel were transferred onto a supported nitrocellulose membrane. Selective mouse monoclonal anti-COX-1 (COX-111) or anti-COX-2 (COX-229) antibodies were used to detect COX-1 and COX-2 proteins, respectively, as previously described. 23 Protein bands on the membrane were visualized by an Enhanced Chemiluminescence detection system (ECL from General Electric).
Characterization of cell differentiation
NB4 cells were grown in the presence of As 2 O 3 (0.5 mM), ATRA (1 or 0.1 mM) or both for 3 days in the absence or presence of 10 mM indomethacin, a nonselective COX-1/COX-2 inhibitor or 10 mM SC58560, a COX-1-selective inhibitor. Cell maturation was evaluated on the basis of cellular morphology, changes in cell surface antigen and NBT (Sigma-Aldrich) assay. Briefly, cytospin slides stained with May-Grunwald-Giemsa were analyzed for cell morphology by means of light microscopy.
Analysis of cell surface myeloid-specific antigen CD11c was performed using a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA). Myeloid differentiation was also evaluated by the NBT reduction activity. Briefly, cells were incubated with 0.04 mg ml À1 of phorbol 12-myristate 13-acetate and 1 mg ml
À1
NBT for 15 min at 37 1C, and then loaded on the slide glass and stained with safranin O. Positively stained cells were counted in groups of 500 cells under the microscope.
Data analyses
Autoradigrams obtained after western blot analyses were scanned using Epson1680 proscanner and densitometric analysis was performed using Scion software. Statistics analysis was performed using t-test (Sigma Stat from SPSS, Statistical Packages for the Social Sciences, Chicago, IL, USA).
Results
As 2 O 3 inhibits ATRA-dependent cyclooxygenase activity and expression in NB4 cells
We have recently demonstrated in NB4 cells that ATRA increased the COX-1 expression. 19 To assess the effect of As 2 O 3 on ATRA-dependent COX-1 expression during cell differentiation, cells were treated with 0.1 or 1 mM ATRA, and COX-1 activity was measured by the conversion of arachidonic acid into PGE 2 . Figures 1a and b (Figures  1a and b) . Addition of 10 mM of indomethacin, a COX-1/COX-2 inhibitor, resulted in an inhibition of PGE 2 formation in both ATRA or ATRA þ As 2 O 3 -treated NB4 cells. Similarly, addition of 10 mM of SC58560, a COX-1-selective inhibitor, decreased basal and As 2 O 3 -dependent PGE 2 production, indicating that COX-1 accounted for PGE 2 production in NB4 cells. Importantly, addition of SC58560 decreased PGE 2 formation in both ATRA-and ATRA þ As 2 O 3 -treated NB4 cells (Figures 1a and b) .
COX-1 protein expression was assessed in these cells by western blot. As shown in Figure 2 , treatment with 0.1 mM ATRA increased COX-1 expression as compared to untreated cells (2.3±0.84 fold increase of control, mean±s.e., n ¼ 3). Treatment with 0.5 mM As 2 O 3 significantly inhibited COX-1 induction by ATRA (1.23±0.61 fold of control, mean±s.e., Po0.05, paired t-test). Treatment of cells with As 2 O 3 alone resulted in a slight decrease in COX-1 expression (Figure 2 ). COX-2 protein was not detected in untreated and ATRA-treated NB4 cells, or upon treatment of As 2 O 3 for 3 or 6 days as previously described (data not shown). 19 Reverse transcription (RT)-PCR analysis revealed similar COX-1 transcript level in ATRA-and ATRA/ As 2 O 3 -treated NB-4 cells, indicating that As 2 O 3 -induced inhibition of COX-1 expression does not involve regulations at the transcriptional level.
As 2 O 3 and indomethacin alter ATRA-dependent NB4 cell differentiation
We next examined the effect of co-treatment with COX inhibitors and As 2 O 3 on NB4 cells differentiation. For the study of myeloid cell maturation, we have monitored NB4 cell differentiation using three classical assays, cell morphology,
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A Habib et al CD11c expression and NBT reduction test, a measure of granulocyte maturation. Treatment of NB4 cells with ATRA alone resulted in a high degree of granulocytic differentiation, as expected. Treatment of NB4 cells with 0.5 mM As 2 O 3 showed nucleus aggregation occupying all cytoplasmic space, indicative of apoptosis. Co-treatment with ATRA and As 2 O 3 showed both induction of cell death and cell differentiation, the latter was slightly reduced as compared to ATRA alone (Figure 3a) . Pretreatment of NB4 cells with 10 mM indomethacin decreased the maturation of NB4 cells in response to ATRA as previously reported. 19 Importantly, pretreatment with indomethacin dramatically blocked the differentiation of cells treated with the combination of ATRA and As 2 O 3 ( Figure 3a) . These morphological data were further supported by the results of the NBT test (Figures 3b and d) and the CD11c membrane expression (Figure 3c ), all showing that indomethacin dramatically blocked the differentiation of cells treated with the combination of ATRA and As 2 O 3 .
Effect of PGE 2 on NB4 differentiation and CD11c expression
To directly demonstrate that the effect of COX inhibition on the differentiation of NB4 treated with the combination of ATRA and arsenic is mediated, at least in part, by PGE 2 , NB4 cells were co-incubated with PGE 2 in the presence or absence of ATRA, As 2 O 3 and indomethacin. PGE 2 reversed the negative effect of indomethacin on NB4 differentiation, as detected by CD11c expression (Figure 4a ) and NBT test (Figure 4b ).
Discussion
In this report, we confirm our previous findings that ATRA induces COX-1 expression and PGE 2 secretion in NB4 cells. We show additionally that As 2 O 3 inhibits ATRA-dependent COX-1 activity and expression in NB4 cells and that NSAIDs significantly block differentiation of ATRA-and As 2 O 3 -treated NB4 cells.
The molecular mechanisms of ATRA-induced COX-1 activity and the effect of the resultant PGE 2 secretion on APL cell differentiation remain to be elucidated. COX-1 is largely considered constitutively expressed. However, retinoid isomers including ATRA and 9-cis-RA were described to induce COX-1 in human premonocytic U937 cells 20 and human Arsenic inhibits ATRA-induced COX-1 in NB4 cells A Habib et al neuroblastoma cell lines. 21 ATRA-induced COX-1 upregulation may be mediated by the Sp1 transcription factor, which is significantly upregulated during myeloid differentiation, and has been reported to mediate ATRA responsiveness of several genes devoid of RAR-responsive element (RARE) motifs. [27] [28] [29] In that sense, the COX-1 promoter contains two Sp1-binding sequences but no canonical RARE. 30 Previous reports described a prodifferentiating role of PGE 2 , the main product of COX-1 activity, in myelopoiesis. PGE 2 and its analogs induce neutrophilia and increase survival of irradiated rodents. [31] [32] [33] These PGE 2 effects are likely mediated by PGE 2 -induced increase of intracellular cyclic AMP. Indeed, cAMP is well known to synergize with retinoic acid to trigger differentiation in several cell types, including APL cells. 34, 35 Recently, Kamashev et al. 36 showed that cAMP restored both retinoic acid-triggered differentiation and PML-RARA transcriptional activation in mutant retinoic acid-resistant APL cells. They also demonstrated that APL cell differentiation parallels transcriptional activation through PML-RARA-RXR oligomers and that those are functionally targeted by cAMP, identifying this agent as another oncogene-targeted therapy. 36 Overall, ATRA-induced COX-1 activity may, at least partially, mediate ATRA-induced differentiation through an autocrine loop of PGE 2 secretion.
We also show that As 2 O 3 inhibits ATRA-dependent COX-1 activity and expression in NB4 cells. These As 2 O 3 effects may occur at levels other than transcriptional or related to COX-1 mRNA stability since we did not observe significant changes in COX-1 transcript levels. Hence, these effects may be due to As 2 O 3 -induced, caspase-or proteasome-mediated, COX-1 protein degradation. However, although As 2 O 3 partially attenuates ATRA-induced COX-1 activation, COX-1 activity and PGE 2 levels in ATRA/As 2 O 3 -treated NB4 cells, although slightly reduced compared to ATRA alone, remain sufficiently elevated to induce significant differentiation. However, addition of NSAIDs decreases differentiation induced by ATRA and almost totally blocks differentiation induced by ATRA/As 2 O 3 . These findings may have important clinical implications for APL therapy. NSAIDs are frequently used as analgesics/antipyretics in ATRA-treated APL patients. If differentiation is important in APL therapy, NSAIDs that inhibit COX-1 activity, and therefore Arsenic inhibits ATRA-induced COX-1 in NB4 cells A Habib et al
